Kings Point Capital Management’s Invesco S&P 500 Equal Weight Technology ETF RSPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,070
Closed -$31K 651
2021
Q3
$31K Hold
1,070
﹤0.01% 433
2021
Q2
$31K Hold
1,070
﹤0.01% 411
2021
Q1
$29K Hold
1,070
﹤0.01% 406
2020
Q4
$27K Hold
1,070
﹤0.01% 389
2020
Q3
$23K Hold
1,070
﹤0.01% 397
2020
Q2
$21K Hold
1,070
﹤0.01% 359
2020
Q1
$17K Sell
1,070
-6,460
-86% -$122K ﹤0.01% 390
2019
Q4
$149K Buy
7,530
+6,460
+604% +$121K 0.02% 205
2019
Q3
$19K Hold
1,070
﹤0.01% 407
2019
Q2
$19K Hold
1,070
﹤0.01% 358
2019
Q1
$18K Hold
1,070
﹤0.01% 316
2018
Q4
$15K Hold
1,070
﹤0.01% 330
2018
Q3
$18K Hold
1,070
﹤0.01% 322
2018
Q2
$17K Buy
+1,070
New +$16.8K ﹤0.01% 327
2018
Q1
Sell
-1,070
Closed -$15K 378
2017
Q4
$15K Buy
+1,070
New +$15.2K ﹤0.01% 339

Other funds holding RSPT

Kings Point Capital Management's RSPT Position: Q4 2021 in Review

Kings Point Capital Management sold out of Invesco S&P 500 Equal Weight Technology ETF (RSPT) in Q4 2021, closing a stake of 1,070 shares — an estimated $31K sold.

Kings Point Capital Management first reported a position in RSPT in Q4 2017 and held it in 15 quarters. The position peaked at $149K in Q4 2019. 301 funds tracked by Wall St. Rank hold RSPT as of Q4 2021.

  • Kings Point Capital Management reported no remaining Invesco S&P 500 Equal Weight Technology ETF position as of Q4 2021 after selling out during the quarter.
  • Kings Point Capital Management sold 1,070 Invesco S&P 500 Equal Weight Technology ETF shares in Q4 2021, an estimated $31K.
  • Kings Point Capital Management first reported a position in Invesco S&P 500 Equal Weight Technology ETF in Q4 2017 and held it in 15 quarters.
  • Kings Point Capital Management's Invesco S&P 500 Equal Weight Technology ETF position peaked at $149K in Q4 2019.
  • 301 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Technology ETF as of Q4 2021.

Based on Kings Point Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.